LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Oisin Biotechnologies Inc.
Headquarters:
Seattle, WA, United States of America
Website:
http://www.oisinbio.com
Year Founded:
2014
Status:
Private
BioCentury
|
Jul 25, 2024
Finance
Venture Report: Third Arc’s $165M series A; Brenig heads for clinic with $65M round
Plus: Flagship-backed Abiologics launches; and rounds for GRO, Autobahn and Rona
Read More
BioCentury
|
Jan 6, 2022
Deals
Lilly-Entos deal underscores importance of nucleic acid delivery tech
Partners to use Canadian biotech’s Fusogenix platform for non-viral nucleic acid delivery in neurology
Read More
Items per page:
10
1 - 2 of 2
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help